[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Glycoprotein Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 90 pages | ID: G4AD493DECDFEN
Market Monitor Global

US$ 2,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Glycoproteins are proteins that contain oligosaccharide chains (glycans) covalently attached to polypeptide side-chains. The carbohydrate is attached to the protein in a cotranslational or posttranslational modification. This process is known as glycosylation. Secreted extracellular proteins are often glycosylated.
This report contains market size and forecasts of Glycoprotein in US, including the following market information:
US Glycoprotein Market Revenue, 2015-2020, 2021-2026, ($ millions)
US Glycoprotein Market Consumption, 2015-2020, 2021-2026, (mg)
US Glycoprotein Production Capacity, 2015-2020, 2021-2026, (mg)
Top Five Competitors in US Glycoprotein Market 2019 (%)
The global Glycoprotein market was valued at 479.4 million in 2019 and is projected to reach US$ 494.2 million by 2026, at a CAGR of 0.8% during the forecast period. While the Glycoprotein market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glycoprotein manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Glycoprotein production and consumption in US

Total Market by Segment:

US Glycoprotein Market, By Type, 2015-2020, 2021-2026 ($ millions) & (mg)
US Glycoprotein Market Segment Percentages, By Type, 2019 (%)
  • N-linkage
  • O-linkage
  • Other
US Glycoprotein Market, By Application, 2015-2020, 2021-2026 ($ millions) & (mg)
US Glycoprotein Market Segment Percentages, By Application, 2019 (%)
  • Hospital
  • Research Institutes
  • Other
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Glycoprotein Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)
Total Glycoprotein Market Competitors Revenues Share in US, by Players 2019 (%)
Total US Glycoprotein Market Competitors Sales, by Players 2015-2020 (Estimated), (mg)
Total US Glycoprotein Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
  • Sigma
  • Creative Diagnostics
  • R&D Systems
  • Enzo Life Sciences
  • Thermo Fisher Scientific
  • Epitope Diagnostics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glycoprotein Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 US Glycoprotein Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: US GLYCOPROTEIN OVERALL MARKET SIZE

2.1 US Glycoprotein Market Size: 2020 VS 2026
2.2 US Glycoprotein Revenue, Prospects & Forecasts: 2015-2026
2.3 US Glycoprotein Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Glycoprotein Players in US (including Foreign and Local Companies)
3.2 Top US Glycoprotein Companies Ranked by Revenue
3.3 US Glycoprotein Revenue by Companies (including Foreign and Local Companies)
3.4 US Glycoprotein Sales by Companies (including Foreign and Local Companies)
3.5 US Glycoprotein Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Glycoprotein Companies in US, by Revenue in 2019
3.7 US Manufacturers Glycoprotein Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glycoprotein Players in US
  3.8.1 List of US Tier 1 Glycoprotein Companies
  3.8.2 List of US Tier 2 and Tier 3 Glycoprotein Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - US Glycoprotein Market Size Markets, 2020 & 2026
  4.1.2 N-linkage
  4.1.3 O-linkage
  4.1.4 Other
4.2 By Type - US Glycoprotein Revenue & Forecasts
  4.2.1 By Type - US Glycoprotein Revenue, 2015-2020
  4.2.2 By Type - US Glycoprotein Revenue, 2021-2026
  4.2.3 By Type - US Glycoprotein Revenue Market Share, 2015-2026
4.3 By Type - US Glycoprotein Sales & Forecasts
  4.3.1 By Type - US Glycoprotein Sales, 2015-2020
  4.3.2 By Type - US Glycoprotein Sales, 2021-2026
  4.3.3 By Type - US Glycoprotein Sales Market Share, 2015-2026
4.4 By Type - US Glycoprotein Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - US Glycoprotein Market Size, 2020 & 2026
  5.1.2 Hospital
  5.1.3 Research Institutes
  5.1.4 Other
5.2 By Application - US Glycoprotein Revenue & Forecasts
  5.2.1 By Application - US Glycoprotein Revenue, 2015-2020
  5.2.2 By Application - US Glycoprotein Revenue, 2021-2026
  5.2.3 By Application - US Glycoprotein Revenue Market Share, 2015-2026
5.3 By Application - US Glycoprotein Sales & Forecasts
  5.3.1 By Application - US Glycoprotein Sales, 2015-2020
  5.3.2 By Application - US Glycoprotein Sales, 2021-2026
  5.3.3 By Application - US Glycoprotein Sales Market Share, 2015-2026
5.4 By Application - US Glycoprotein Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Sigma
  6.1.1 Sigma Corporate Summary
  6.1.2 Sigma Business Overview
  6.1.3 Sigma Glycoprotein Major Product Offerings
  6.1.4 Sigma Sales and Revenue in US (2015-2020)
  6.1.5 Sigma Key News
6.2 Creative Diagnostics
  6.2.1 Creative Diagnostics Corporate Summary
  6.2.2 Creative Diagnostics Business Overview
  6.2.3 Creative Diagnostics Glycoprotein Major Product Offerings
  6.2.4 Creative Diagnostics Sales and Revenue in US (2015-2020)
  6.2.5 Creative Diagnostics Key News
6.3 R&D Systems
  6.3.1 R&D Systems Corporate Summary
  6.3.2 R&D Systems Business Overview
  6.3.3 R&D Systems Glycoprotein Major Product Offerings
  6.3.4 R&D Systems Sales and Revenue in US (2015-2020)
  6.3.5 R&D Systems Key News
6.4 Enzo Life Sciences
  6.4.1 Enzo Life Sciences Corporate Summary
  6.4.2 Enzo Life Sciences Business Overview
  6.4.3 Enzo Life Sciences Glycoprotein Major Product Offerings
  6.4.4 Enzo Life Sciences Sales and Revenue in US (2015-2020)
  6.4.5 Enzo Life Sciences Key News
6.5 Thermo Fisher Scientific
  6.5.1 Thermo Fisher Scientific Corporate Summary
  6.5.2 Thermo Fisher Scientific Business Overview
  6.5.3 Thermo Fisher Scientific Glycoprotein Major Product Offerings
  6.5.4 Thermo Fisher Scientific Sales and Revenue in US (2015-2020)
  6.5.5 Thermo Fisher Scientific Key News
6.6 Epitope Diagnostics
  6.6.1 Epitope Diagnostics Corporate Summary
  6.6.2 Epitope Diagnostics Business Overview
  6.6.3 Epitope Diagnostics Glycoprotein Major Product Offerings
  6.6.4 Epitope Diagnostics Sales and Revenue in US (2015-2020)
  6.6.5 Epitope Diagnostics Key News
6.7 BD Biosciences
  6.6.1 BD Biosciences Corporate Summary
  6.6.2 BD Biosciences Business Overview
  6.6.3 BD Biosciences Glycoprotein Major Product Offerings
  6.4.4 BD Biosciences Sales and Revenue in US (2015-2020)
  6.7.5 BD Biosciences Key News

7 GLYCOPROTEIN PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Glycoprotein Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
  7.1.1 US Glycoprotein Production Capacity, 2015-2026
  7.1.2 US Glycoprotein Production 2015-2026
  7.1.3 US Glycoprotein Production Value 2015-2026
7.2 Key Local Glycoprotein Manufacturers in US
  7.2.1 US Key Local Glycoprotein Manufacturers Production Capacity
  7.2.2 US Key Local Glycoprotein Manufacturers Production
  7.2.3 US Key Local Glycoprotein Manufacturers Production Value
  7.2.4 The Proportion of Glycoprotein Production Sold in US and Sold Other Than US by Manufacturers
7.3 Glycoprotein Export and Import in US
  7.3.1 US Glycoprotein Export Market
  7.3.2 US Glycoprotein Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for US Glycoprotein Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON GLYCOPROTEIN SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Glycoprotein Distributors and Sales Agents in US

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Glycoprotein in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Glycoprotein Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Glycoprotein Revenue Share by Companies, 2015-2020
Table 5. US Glycoprotein Sales by Companies, (mg), 2015-2020
Table 6. US Glycoprotein Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Glycoprotein Price (2015-2020) (USD/mg)
Table 8. US Manufacturers Glycoprotein Product Type
Table 9. List of US Tier 1 Glycoprotein Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Glycoprotein Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Glycoprotein Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Glycoprotein Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Glycoprotein Sales in US (mg), 2015-2020
Table 14. By Type - Glycoprotein Sales in US (mg), 2021-2026
Table 15. By Application - Glycoprotein Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Glycoprotein Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Glycoprotein Sales in US, (mg), 2015-2020
Table 18. By Application - Glycoprotein Sales in US, (mg), 2021-2026
Table 19. Sigma Corporate Summary
Table 20. Sigma Glycoprotein Product Offerings
Table 21. Sigma Glycoprotein Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)
Table 22. Creative Diagnostics Corporate Summary
Table 23. Creative Diagnostics Glycoprotein Product Offerings
Table 24. Creative Diagnostics Glycoprotein Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)
Table 25. R&D Systems Corporate Summary
Table 26. R&D Systems Glycoprotein Product Offerings
Table 27. R&D Systems Glycoprotein Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)
Table 28. Enzo Life Sciences Corporate Summary
Table 29. Enzo Life Sciences Glycoprotein Product Offerings
Table 30. Enzo Life Sciences Glycoprotein Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)
Table 31. Thermo Fisher Scientific Corporate Summary
Table 32. Thermo Fisher Scientific Glycoprotein Product Offerings
Table 33. Thermo Fisher Scientific Glycoprotein Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)
Table 34. Epitope Diagnostics Corporate Summary
Table 35. Epitope Diagnostics Glycoprotein Product Offerings
Table 36. Epitope Diagnostics Glycoprotein Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)
Table 37. BD Biosciences Corporate Summary
Table 38. BD Biosciences Glycoprotein Product Offerings
Table 39. BD Biosciences Glycoprotein Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2015-2020)
Table 40. Glycoprotein Production Capacity (mg) of Local Manufacturers in US, 2015-2020
Table 41. Glycoprotein Production (mg) of Local Manufacturers in US, 2015-2020
Table 42. US Glycoprotein Production Market Share of Local Manufacturers, 2015-2020
Table 43. Glycoprotein Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 44. US Glycoprotein Production Value Market Share of Local Manufacturers, 2015-2020
Table 45. The Percentage of Glycoprotein Production Sold in US and Sold Other Than US by Manufacturers
Table 46. The Percentage of Glycoprotein Production Sold in US and Sold Other Than US by Manufacturers
Table 47. Dangeguojia Glycoprotein Sales (Consumption), Production, Export and Import, 2015-2020
Table 48. Raw Materials and Suppliers
Table 49. Glycoprotein Downstream Clients in US
Table 50. Glycoprotein Distributors and Sales Agents in US

LIST OF FIGURES

Figure 1. Glycoprotein Segment by Type
Figure 2. Glycoprotein Segment by Application
Figure 3. Dangeguojia Glycoprotein Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Glycoprotein Market Size in US, (US$, Mn) & (mg): 2020 VS 2026
Figure 6. US Glycoprotein Revenue, 2015-2026 (US$, Mn)
Figure 7. Glycoprotein Sales in US: 2015-2026 (mg)
Figure 8. The Top 3 and 5 Players Market Share by Glycoprotein Revenue in 2019
Figure 9. By Type - US Glycoprotein Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Glycoprotein Market Share, 2015-2020
Figure 11. By Type - US Glycoprotein Market Share, 2020-2026
Figure 12. By Type - US Glycoprotein Price (USD/mg), 2015-2026
Figure 13. By Application - Glycoprotein Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Glycoprotein Market Share, 2015-2020
Figure 15. By Application - US Glycoprotein Market Share, 2020-2026
Figure 16. By Application -US Glycoprotein Price (USD/mg), 2015-2026
Figure 17. US Glycoprotein Production Capacity (mg), 2015-2026
Figure 18. US Glycoprotein Actual Output (mg), 2015-2026
Figure 19. US Glycoprotein Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Glycoprotein Export Destination, 2019
Figure 21. The Source of Imports of US Glycoprotein, 2019
Figure 22. PEST Analysis for US Glycoprotein Market in 2020
Figure 23. Glycoprotein Market Opportunities & Trends in US
Figure 24. Glycoprotein Market Drivers in US
Figure 25. Glycoprotein Market Restraints in US
Figure 26. Glycoprotein Industry Value Chain


More Publications